Ziegler Capital Management »

Biosante Pharmaceuticals shares owned by Ziegler Capital Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Ziegler Capital Management from 13F filings

Historical chart of Ziegler Capital Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Ziegler Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Ziegler Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $472k 8.6k 55.14
2023-09-30 $497k 8.6k 58.06
2023-06-30 $463k 8.6k 53.83

More positions owned by Ziegler Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Home Depot (HD)
Costco Wholesale Corporation (COST)
Broadcom (AVGO)
Adobe Systems Incorporated (ADBE)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
Coca-Cola Company (KO)

View all positions for Ziegler Capital Management

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Assenagon Asset Management
Principal Financial Group
WEDGE Capital Management L

View all funds holding Biosante Pharmaceuticals